These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32301649)

  • 1. The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis.
    Brown L; Vranjkovic O; Li J; Yu K; Al Habbab T; Johnson H; Brown K; Jablonski MR; Dechairo B
    Pharmacogenomics; 2020 Jun; 21(8):559-569. PubMed ID: 32301649
    [No Abstract]   [Full Text] [Related]  

  • 2. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.
    Rosenblat JD; Lee Y; McIntyre RS
    J Clin Psychiatry; 2017 Jun; 78(6):720-729. PubMed ID: 28068459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis.
    Rosenblat JD; Lee Y; McIntyre RS
    J Affect Disord; 2018 Dec; 241():484-491. PubMed ID: 30149336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
    Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF
    Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(4):1-39. PubMed ID: 28515818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.
    Forester BP; Parikh SV; Weisenbach S; Ajilore O; Vahia I; Rothschild AJ; Thase ME; Dunlop BW; DeBattista C; Conway CR; Shelton RC; Macaluso M; Li J; Traxler P; Logan J; Brown L; Dechairo B; Greden JF
    Am J Geriatr Psychiatry; 2020 Sep; 28(9):933-945. PubMed ID: 32513518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial.
    Thase ME; Parikh SV; Rothschild AJ; Dunlop BW; DeBattista C; Conway CR; Forester BP; Mondimore FM; Shelton RC; Macaluso M; Li J; Brown K; Jablonski MR; Greden JF
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31721487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
    Winner JG; Carhart JM; Altar CA; Allen JD; Dechairo BM
    Discov Med; 2013 Nov; 16(89):219-27. PubMed ID: 24229738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial.
    Tiwari AK; Zai CC; Altar CA; Tanner JA; Davies PE; Traxler P; Li J; Cogan ES; Kucera MT; Gugila A; Braganza N; Emmerson H; Zai G; Müller DJ; Levitan R; Kloiber S; Daskalakis ZJ; Frey BN; Bowen JM; Tarride JE; Tytus R; Chandrasena R; Voudouris N; Taylor VH; Tempier R; Sharma V; Vasudev A; Dzongowski P; Pliamm L; Greenspoon T; Dechairo BM; Kennedy JL
    Transl Psychiatry; 2022 Mar; 12(1):101. PubMed ID: 35288545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder.
    Shelton RC; Parikh SV; Law RA; Rothschild AJ; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Macaluso M; Hain DT; Aguilar AL; Brown K; Lewis DJ; Jablonski MR; Greden JF
    Psychiatry Res; 2020 Aug; 290():113017. PubMed ID: 32485484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
    Bousman CA; Arandjelovic K; Mancuso SG; Eyre HA; Dunlop BW
    Pharmacogenomics; 2019 Jan; 20(1):37-47. PubMed ID: 30520364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
    Oslin DW; Lynch KG; Shih MC; Ingram EP; Wray LO; Chapman SR; Kranzler HR; Gelernter J; Pyne JM; Stone A; DuVall SL; Lehmann LS; Thase ME; ; Aslam M; Batki SL; Bjork JM; Blow FC; Brenner LA; Chen P; Desai S; Dieperink EW; Fears SC; Fuller MA; Goodman CS; Graham DP; Haas GL; Hamner MB; Helstrom AW; Hurley RA; Icardi MS; Jurjus GJ; Kilbourne AM; Kreyenbuhl J; Lache DJ; Lieske SP; Lynch JA; Meyer LJ; Montalvo C; Muralidhar S; Ostacher MJ; Paschall GY; Pfeiffer PN; Prieto S; Przygodzki RM; Ranganathan M; Rodriguez-Suarez MM; Roggenkamp H; Schichman SA; Schneeweis JS; Simonetti JA; Steinhauer SR; Suppes T; Umbert MA; Vassy JL; Voora D; Wiechers IR; Wood AE
    JAMA; 2022 Jul; 328(2):151-161. PubMed ID: 35819423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
    Hall-Flavin DK; Winner JG; Allen JD; Carhart JM; Proctor B; Snyder KA; Drews MS; Eisterhold LL; Geske J; Mrazek DA
    Pharmacogenet Genomics; 2013 Oct; 23(10):535-48. PubMed ID: 24018772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials.
    Brown LC; Stanton JD; Bharthi K; Maruf AA; Müller DJ; Bousman CA
    Clin Pharmacol Ther; 2022 Dec; 112(6):1303-1317. PubMed ID: 36111494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
    Greden JF; Parikh SV; Rothschild AJ; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Mondimore FM; Shelton RC; Macaluso M; Li J; Brown K; Gilbert A; Burns L; Jablonski MR; Dechairo B
    J Psychiatr Res; 2019 Apr; 111():59-67. PubMed ID: 30677646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists.
    Tanner JA; Davies PE; Voudouris NC; Shahmirian A; Herbert D; Braganza N; Gugila A; Dechairo BM; Kennedy JL
    J Psychiatr Res; 2018 Sep; 104():157-162. PubMed ID: 30081389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
    McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
    J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
    Pérez V; Salavert A; Espadaler J; Tuson M; Saiz-Ruiz J; Sáez-Navarro C; Bobes J; Baca-García E; Vieta E; Olivares JM; Rodriguez-Jimenez R; Villagrán JM; Gascón J; Cañete-Crespillo J; Solé M; Saiz PA; Ibáñez Á; de Diego-Adeliño J; ; Menchón JM
    BMC Psychiatry; 2017 Jul; 17(1):250. PubMed ID: 28705252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of combinatorial pharmacogenomic testing for treatment-resistant major depressive disorder patients.
    Hornberger J; Li Q; Quinn B
    Am J Manag Care; 2015 Jun; 21(6):e357-65. PubMed ID: 26247576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.